LXEO
USDLexeo Therapeutics Inc. Common Stock
Prix en Temps Réel
Graphique des Prix
Métriques Clés
Métriques de Marché
Ouverture
$8.300
Haut
$8.355
Bas
$7.660
Volume
2.85M
Fondamentaux de l'Entreprise
Capitalisation Boursière
597.8M
Industrie
Biotechnologie
Pays
United States
Statistiques de Trading
Volume Moyen
1.04M
Bourse
NGM
Devise
USD
Intervalle sur 52 Semaines
Actualités Connexes
Beyond Traditional Drugs: Novel Platforms Targeting Hard-to-Treat Conditions
Equity InsiderNews Commentary – Conventional small molecule approaches have struggled to address genetic defects and complex disease mechanisms,...
HC Wainwright & Co. Maintains Buy on Lexeo Therapeutics, Lowers Price Target to $13
HC Wainwright & Co. analyst Mitchell S. Kapoor maintains Lexeo Therapeutics with a Buy and lowers the price target from $15 to $13.
Chardan Capital Maintains Buy on Lexeo Therapeutics, Raises Price Target to $17
Chardan Capital analyst Geulah Livshits maintains Lexeo Therapeutics with a Buy and raises the price target from $15 to $17.
Lexeo Therapeutics Announces Progress in FDA Discussions for Accelerated Approval Pathway and Positive Interim Clinical Data for LX2006 in Friedreich Ataxia Cardiomyopathy
U.S. Food and Drug Administration (FDA) open to pooling data from ongoing Phase I/II studies of LX2006 with pivotal data to support a Biologics License Application (BLA) for Accelerated Approval Interim clinical data
Actions Connexes
THW
abrdn World Healthcare Fund Shares of Beneficial Interest
BASE
Couchbase Inc.
ARCH
Arch Resources Inc.
NPABW
New Providence Acquisition Corp. II Warrant
HTFB
Horizon Technology Finance Corporation 4.875% Notes due 2026
Restez Informé
Configurez des alertes de prix, recevez des mises à jour d'analyses IA et des actualités de marché en temps réel.